Stellaromics

Natick, United States

Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology.

$80.0M raised

Feb 2025

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Stellaromics raised?

Stellaromics has raised $80.0M in total funding. The most recent round was Series B. The last funding was announced in February 2025.

Who are Stellaromics's investors?

Stellaromics's investors include Stanford University, Plaisance Capital Management, Catalyst4.

Where is Stellaromics headquartered?

Stellaromics is headquartered in Natick, United States.

What does Stellaromics do?

Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology.

What stage is Stellaromics at?

Stellaromics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 11, 2025.

MLA

"Stellaromics — Funding & Investors." VCBacked, February 11, 2025, https://www.vcbacked.co/company/stellaromics. Accessed July 2, 2026.

APA

VCBacked. (2025). Stellaromics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/stellaromics

Wikipedia (cite web)

{{cite web |title=Stellaromics — Funding & Investors |url=https://www.vcbacked.co/company/stellaromics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 11, 2025.